Profound Medical (PROF) Receivables - Net (2018 - 2026)

Profound Medical has reported Receivables - Net for 9 years, with the latest figure at $9.4 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables - Net rose 95.01% year-over-year to $9.4 million; the trailing twelve-month figure through Mar 2026 stood at $9.4 million (up 95.01% YoY), and the FY2025 full-year result was $7.2 million, up 2.2% from the prior year.
• Receivables - Net for Q1 2026 stood at $9.4 million, up from $7.2 million in the prior quarter.
• The five-year high for Receivables - Net was $9.4 million in Q1 2026, with the low at $4.1 million in Q2 2025.
• Average Receivables - Net over 5 years is $6.5 million, with a median of $6.5 million recorded in 2022.
• Year-over-year, Receivables - Net tumbled 39.03% in 2025 and jumped 95.01% in 2026.
• Tracing PROF's Receivables - Net over 5 years: stood at $6.3 million in 2022, then rose by 14.88% to $7.3 million in 2023, then declined by 3.33% to $7.0 million in 2024, then increased by 2.2% to $7.2 million in 2025, then soared by 30.88% to $9.4 million in 2026.
• The last three Receivables - Net figures came in at $9.4 million (Q1 2026), $7.2 million (Q4 2025), and $8.2 million (Q3 2025), per Business Quant data.

Peer Comparison